Search

Home > New FDA Approvals > 063 - Boston Scientific's Spectra WaveWriter chronic pain device; FDA panel votes against recommending approval for TLANDO; Mental health watchdog against FDA approval of digital Sensor in aripiprazole
Podcast: New FDA Approvals
Episode:

063 - Boston Scientific's Spectra WaveWriter chronic pain device; FDA panel votes against recommending approval for TLANDO; Mental health watchdog against FDA approval of digital Sensor in aripiprazole
Category: Science & Medicine
Duration: 00:10:35
Publish Date: 2018-01-12 07:00:00
Description:

January 12, 2018 

0:33 FDA approves Boston Scientific's Spectra WaveWriter chronic pain device

http://news.bostonscientific.com/2018-01-11-Boston-Scientific-Receives-U-S-FDA-Approval-for-Spectra-WaveWriter-TM-Spinal-Cord-Stimulator-System 4:03 FDA panel votes against recommending approval for Lipocine's TLANDO

http://markets.businessinsider.com/news/stocks/Lipocine-Announces-Outcome-of-FDA-Advisory-Committee-Meeting-for-TLANDO-Testosterone-Replacement-Therapy-in-Adult-Males-with-Hypogonadism-1001995864

6:06 Psychiatry’s Brave New World--FDA Approves Digital Sensor in Antipsychotic Drug to Enforce https://www.prnewswire.com/news-releases/psychiatrys-brave-new-world--fda-approves-digital-sensor-in-antipsychotic-drug-to-enforce-prescription-compliance-300581439.html

8:45 Audible 30 day free trial newfdaapprovals.com/audible

9:19 Nascent Medical info@nascentmc.com
Total Play: 0